FREE Case Review (866) 588-0600

Abilify Lawsuits Consolidated in Florida

Federal lawsuits alleging compulsive gambling and other uncontrollable behavior from the antipsychotic drug Abilify have been consolidated into a multidistrict litigation (MDL) in Florida.

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has consolidated over 20 lawsuits alleging compulsive gambling side effects from the antipsychotic drug Abilify (generic: aripiprazole) in federal court in Florida.

Free Confidential Lawsuit Evaluation: If you or a loved one experienced compulsive behaviors after taking Abilify, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.

What’s the Problem?

October 6, 2016 – At least 22 lawsuits currently pending in 12 districts will be centralized before Chief Judge M. Casey Rodgers in the Northern District of Florida, according to the Transfer Order (PDF).

Court filings indicate that about 24 million prescriptions have been filled for Abilify since it was first approved by the U.S. Food & Drug Administration (FDA) in November 2002. While drugmaker Bristol-Myers Squibb (BMS) does mention the potential for compulsive behavior on the medication’s labeling, the verbiage “does not entirely reflect the nature of the impulse-control risk,” according to the FDA.

Abilify is prescribed for the treatment of schizophrenia, bipolar disorder and major depressive disorders. Since the drug’s approval through earlier this year, there have been at least 184 adverse event reports of severe impulse-control problems in patients treated with Abilify.

In May 2016, FDA issued a Drug Safety Alert indicating that use of aripiprazole (the active ingredient in Abilify) had been linked to compulsive urges which can lead to uncontrollable gambling, shopping, eating and sexual addiction (hyersexuality). These rare but serious impulse-control problems reportedly stop when patients discontinued Abilify or reduced the dosage, according to the FDA.

Florida was initially proposed as the MDL venue by a couple who filed one of the dozens of lawsuits alleging that Abilify’s manufacturers failed to adequately warn consumers about the risk of pathological gambling with the drug. BMS and Otsuka Pharmaceutical consented to the couple’s motion, stressing that Judge Rodgers is already overseeing 2 Abilify lawsuits in the Northern District of Pensacola. The litigation is: In Re: Abilify Compulsive Behavior Products Liability Litigation – MDL No. 2734.

Do I Have an Abilify Lawsuit?

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Abilify lawsuits. We are handling individual litigation nationwide and currently accepting new compulsive gambling cases in all 50 states.

Free Case Evaluation: Again, if you or a loved one experienced financial loss, family problems or legal consequences as a result of compulsive gambling while taking Abilify, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
Awards & recognition